• 1
  • 2
  • 3
    Petrache I, Diab K, Knox KS et al. HIV associated pulmonary emphysema: a review of the literature and inquiry into its mechanism. Thorax 2008; 63: 463469.
  • 4
    O'Donell CR, Bader MB, Zibrak JD, Jensen WA, Rose RM. Abnormal airway function in individuals with the adquiried immunodeficiency syndrome. Chest 1998; 94: 945948.
  • 5
    Mocroft A, Brettle R, Kirk O et al.; EuroSIDA study group. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS 2002; 16: 16631671.
  • 6
    Diaz PT, Clanton TL, Pacht ER. Emphysema-like pulmonary disease associated with human immunodeficiency virus infection. Ann Intern Med 1992; 116: 124128.
  • 7
    Diaz PT, King MA, Pacht ER et al. Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med 2000; 132: 369372.
  • 8
    Crothers K, Butt AA, Gibert CL, Rodriguez-Barradas MC, Crystal S, Justice AC. Increased COPD among HIV-positive compared to HIVnegative veterans. Chest 2006; 130: 13261333.
  • 9
    George MP, Kannass M, Sciurba FC, Morris A. Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era. PLoS ONE 2009; 4: e6328.
  • 10
    Gingo MR, George MP, Kessinger CJ et al. Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era. Am J Respir Crit Care Med 2010; 182: 790796.
  • 11
    Crothers K, Huang L, Goulet JL et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med 2011; 183: 388395.
  • 12
    Hirani A, Cavallazzi R, Vasu T et al. Prevalence of obstructive lung disease in HIV population: a cross sectional study. Respir Med 2011; 105: 16551661.
  • 13
    Drummond MB, Kirk GD, Ricketts EP et al. Cross sectional analysis of respiratory symptoms in an injection drug user cohort: the impact of obstructive lung disease and HIV. BMC Pulm Med 2010; 10: 27.
  • 14
    Kristoffersen US, Lebech AM, Mortensen J, Gerstoft J, Gutte H, Kjaer A. Changes in lung function of HIV-infected patients: a 4.5-year follow-up study. Clin Physiol Funct Imaging 2012; 32: 288295.
  • 15
    Madeddu G, Fois AG, Calia GM et al. Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? Infection 2013; 41: 347353.
  • 16
    Strategies for management of antiretroviral therapy (SMART) Study Group, Emery S, Neuhaus JA. Major clinical outcomes in antiretroviral therapy naive participants and in those not receiving ART at baseline in the SMART study. J Infect Dis 2008; 197: 11331144.
  • 17
    De DAD, Sabin CA, Worm SW, Weber R et al. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. Lancet 2008; 371: 14171426.
  • 18
    Rabe KF, Hurd S, Anzueto A et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 176: 532555.
  • 19
    Gallego MC, Samaniego J, Alonso J, Sánchez A, Carrizo S, Marín JM. Disnea en la EPOC: relación de la escala MRC con la disnea inducida en las pruebas de marcha y de ejercicio cardiopulmonar máximo. Arch Bronconeumol 2002; 38: 112116.
  • 20
    American Thoracic Society Official Statement. Standardization of spirometry. 1994 Update. Am J Respir Crit Care Med 1995; 152: 11071136.
  • 21
    Roca J, Sanchis J, Agustí-Vidal A et al. Spirometric reference values for a mediterranean population. Bull Eur Physiopathol Respir 1998; 22: 217224.
  • 22
    Roca J, Rodriguez-Roisín R, Cobo E, Burgos F, Perez J, Clausen JL. Single-breath carbon monoxide diffusing capacity (DLCO) prediction equations for a mediterranean population. Am Rev Respir Dis 1990; 141: 10261032.
  • 23
    Clausen JL. Pulmonary Function Testing. Guidelines and Controversies. Equipment, Methods and Normal Values. Orlando, FL, Grune & Stratton, Inc., 1984.
  • 24
    Maclntyre N, Crapo R, Viegi G et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26: 720735.
  • 25
    ATS Statement. Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111117.
  • 26
    Pin I, Gibson PG, Kolendowicz R et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47: 2529.
  • 27
    Pizzichini MM, Popov TA, Efthimiadis A et al. Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Am J Respir Crit Care Med 1996; 154 (4 Pt 1): 866869.
  • 28
    Alvarez-Martinez MJ, Miro JM, Valls ME et al. the Spanish PCP Working Group. Sensitivity and specificity of nested and real-time PCR for the detection of Pneumocystis jirovecii in clinical specimens. Diagn Microbiol Infect Dis 2006; 56: 153160.
  • 29
    Grydeland TB, Dirksen A, Coxson HO et al. Quantitative computed tomography:emphysema and airway wall thickness by sex, age and smoking. Eur Respir J 2009; 34: 858865.
  • 30
    Bergin C, Müller NL, Nichols D et al. The diagnosis of Emphysema. A computed tomographic-pathologic correlation. Am Rev Respir Dis 1986; 133: 541546.
  • 31
    Park KJ, Bergin C, Clausen J. Quantitation of emphysema with three-dimensional CT densitometry: comparion with Two-dimensional Analysis, Visual emphysema scores and pulmonary function test results. Radiology 1999; 211: 541547.
  • 32
    LaValley MP. Logistic regression. Circulation 2008; 117: 23952399.
  • 33
    Lele SR, Keim JL, Solymos P. 2013). ResourceSelection: Resource Selection (Probability) Functions for Use-Availability Data. R package version 0.2-3. Available at: (accessed 18 September 2013).
  • 34
    Kohansal R, Martinez-Camblor P, Agusti A, Buist AS, Mannino DM, Soriano JB. The natural history of chronic airflow obstruction revisited: an analysis of the framingham offspring cohort. Am J Respir Crit Care Med 2009; 180: 310.
  • 35
    Miravitlles M, Soriano JB, García-Río F et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009; 64: 863868.
  • 36
    Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009; 374: 733743.
  • 37
    American Thoracic Society. Single breath carbon monoxide diffusing capacity transfer factor). Recommendations for a standard technique 1995, update. Am J Respir Crit Care Med 1996; 152: 21852198.
  • 38
    Stavngaard T, Shaker SB, Bach KS, Stoel BC, Dirksen A. Quantitative assessment of regional emphysema distribution in patients with Chronic Obstructive Pulmonary Disease (COPD). Acta Radiol 2006; 47: 914921.
  • 39
    Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009; 360: 24452454.
  • 40
    Gingo MR, He J, Wittman C et al. Contributors to diffusion impairment in HIV-infected persons. Eur Respir J; doi: 10.1183/09031936.00157712 [Epub ahead of print].
  • 41
    Engelen MP, Deutz NE, Mostert R, Wouters EF, Schols AM. Response of whole-body protein and urea turnover to exercise differs between patients with chronic obstructive pulmonary disease with and without emphysema. Am J Clin Nutr 2003; 77: 868874.
  • 42
    Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J 2009; 34: 380386.
  • 43
    Winstone TA, Man SF, Hull M, Montaner JS, Sin DD. Epidemic of lung cancer in patients with HIV infection. Chest 2013; 143: 305314.